Taken together, these molecular observations provide the basis for speculating that GLP-1 RAs may improve cognitive outcomes and/or modify the disease course of major neurocognitive disorders such as Alzheimer disease and Parkinson disease (PD)
Understanding these limitations helps set realistic expectations and encourages more cautious decision-making, which ultimately reduces risk
Finally, the use of L-carnitine (10-20 mg/kg body weight given as a slow bolus injection) is approved by the US FDA to treat L-carnitine deficiency in subjects with ESRD undergoing hemodialysis (76)
Standard cagrilintide dosing follows a 12-week titration from 0.6mg to 2.4mg weekly (0.6mg weeks 1-4, 1.2mg weeks 5-8, 1.8mg weeks 9-12, 2.4mg week 13+)
Ceiling-effect considerations Single-receptor agonists eventually hit ceiling effects, where increasing dose yields diminishing returns or dose-limiting side effects
Muscle Growth, Recovery and Anti-Inflammation CJC-1295 + Ipamorelin CJC-1295 + Ipamorelin is designed to stimulate natural growth hormone release in controlled physiologic pulses